Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.62
    -0.74 (-0.89%)
     
  • GOLD FUTURES

    2,341.10
    -1.00 (-0.04%)
     
  • DOW

    38,396.22
    -107.47 (-0.28%)
     
  • Bitcoin GBP

    52,153.61
    -1,408.69 (-2.63%)
     
  • CMC Crypto 200

    1,398.67
    -25.43 (-1.79%)
     
  • NASDAQ Composite

    15,684.82
    -11.82 (-0.08%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

How has the Rentokil Initial share price performed over the past year?

It has been 12 months of turmoil for UK shares, with the Covid-19 crisis crashing the economy and unsettling the stock market. Unsurprisingly, investors have been laser-focused on the share prices of some of the UK’s biggest companies - including Rentokil Initial (LON:RTO).

Rentokil Initial is one of just 200 UK-quoted stocks with a market capitalisation of more than £1.0 billion. In fact, the stock is currently valued at £9,954m. These top tier shares include some of the world’s best known companies. They have a huge presence in the investment funds and pension portfolios of millions of savers. They are also some of the biggest dividend payers.

So how have shares in Rentokil Initial performed? Well, over the past 12 months, the stock has seen an absolute return of 23.9%.

But given the volatility of the market in 2020 - which has rocked some industry sectors very badly - it’s also worth looking at how the shares have performed in relation to the overall market.

ADVERTISEMENT

On a relative basis, shares in Rentokil Initial have moved by 48.0% over the past year and by 34.1% over the past six months.

But what now?

GET MORE DATA-DRIVEN INSIGHTS INTO LON:RTO »

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main concern for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news when it comes to the market's biggest stocks is that analysts know these businesses better than most, so they are best-placed to make accurate predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Rentokil Initial, there are currently:

  • 4 Buy recommendations

  • 5 Hold recommendations

  • 0 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.

It's also worth looking at the profile of the stock to understand whether it has strong positive exposure to important factors like Value, Quality and Momentum. On that basis, Stockopedia currently classifies Rentokil Initial as a high flyer. You can read more about what that means here.

What next?

Rentokil Initial is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything.

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Rentokil Initial that you can find out about here.